SCHEMBL51304

SCHEMBL51304

NC(=O)CCCCCCCCC(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
SOAT1 P35610 2/20 0.52
MEN1 O00255 2/20 0.52
TP53 P04637 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2C19 P33261 2/20 0.52
FAAH O00519 1/20 0.52
LMNA P02545 4/20 0.50
PMP22 Q01453 3/20 0.50
NFKB1 P19838 2/20 0.50
TSHR P16473 1/20 0.50
KDM4E B2RXH2 3/20 0.46
ALOX15 P16050 3/20 0.45
ALDH1A1 P00352 2/20 0.45
RECQL P46063 2/20 0.45
PLG P00747 1/20 0.45
THRB P10828 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL42735 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL10536662 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL699936 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL25288050 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL727151 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL25293705 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL15007818 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL25293609 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL517606 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL818928 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3974 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717733-A1 POLYAMIDE RESIN COMPOSITION UBE Corporation (JP) 2026-04-01 EP claimed
US-12577200-B2 High-throughput method to rapidly add chemical moieties to a small molecule library MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2026-03-17 US claimed
US-12568731-B2 Quantum dot film, method for preparing the same, and quantum dot light emitting diode TCL TECHNOLOGY GROUP CORPORATION (CN) 2026-03-03 US claimed
US-12545762-B2 Highly spherical polyamide microparticles and synthesis methods related thereto XEROX CORPORATION (US) 2026-02-10 US claimed
EP-4683911-A1 NOVEL TAG FOR LIQUID-PHASE PEPTIDE SYNTHESIS CordenPharma International GmbH (DE) 2026-01-28 EP claimed
US-20260022407-A1 METHOD, ENZYME COMPOSITION, NUCLEIC ACID COMPOSITION, AND TRANSGENIC MICROORGANISM FOR PRODUCING ISOPRENE GLYCOL NATIONAL YANG MING CHIAO TUNG UNIV (TW) 2026-01-22 US claimed
WO-2025264177-A1 METHOD FOR CLEAVING PROTECTING GROUPS AND ORGANIC COMPOUNDS FROM SUPPORTS POLYPEPTIDE LABORATORIES HOLDING (PPL) AB (SE) 2025-12-26 WO claimed
US-20250320251-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING NOVEL CYCLIC PEPTIDES LISATA THERAPEUTICS INC (US) 2025-10-16 US claimed
US-20250277144-A1 REPAIRING WELLBORE CEMENT STRUCTURES AND RELATED COMPOSITIONS SAUDI ARABIAN OIL COMPANY (SA) 2025-09-04 US claimed
US-12378360-B2 Polyamide particles and methods of production and uses thereof XEROX CORPORATION (US) 2025-08-05 US claimed
US-20040265964-A1 Inducers of recombinant protein expression IMMUNEX CORPORATION 2004-12-30 US claimed
WO-2004096833-A2 INDUCERS OF RECOMBINANT PROTEIN EXPRESSION IMMUNEX CORPORATION (US) 2004-11-11 WO claimed
US-20040180955-A1 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy AU JESSIE L-S (US) 2004-09-16 US claimed
EP-1429713-A2 METHODS AND COMPOSITIONS TO DETERMINE THE CHEMOSENSITIZING DOSE OF SURAMIN USED IN COMBINATION THERAPY Au, Jessie L.S. (US) 2004-06-23 EP claimed
WO-2003026574-A2 METHODS AND COMPOSITIONS TO DETERMINE THE CHEMOSENSITIZING DOSE OF SURAMIN USED IN COMBINATION THERAPY AU JESSIE L-S (US) 2003-04-03 WO claimed
WO-1998028010-A2 USE OF MOIETIES FOR BINDING TO HYALURONAN AND ICAM-1 HYAL PHARMACEUTICAL CORPORATION (CA) 1998-07-02 WO claimed
US-4859558-A Composition with fatty acid bisamide powder developer FUJI XEROX CO., LTD. (JP) 1989-08-22 US claimed
US-4555357-A HEAT RESISTANCE WITH AN AMIDE POLYPLASTICS COMPANY, LTD. (JP) 1985-11-26 US claimed
EP-0005476-B1 PROCESS FOR PREPARING HUMAN INTERFERON Dr. Karl Thomae GmbH (DE) 1981-12-30 EP claimed
EP-0005476-A2 Process for preparing human interferon Dr. Karl Thomae GmbH (DE) 1979-11-28 EP claimed